Global Chronic Wound Care Market Report 2024

The chronic wound care market size has grown strongly in recent years. It will grow from $14.23 billion in 2023 to $15.27 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth observed in the historical period is linked to factors such as an aging population, a rise in the prevalence of chronic diseases, an increased incidence of diabetes, heightened awareness about wound management, and enhanced accessibility to healthcare services.

The chronic wound care market size is expected to see strong growth in the next few years. It will grow to $20.43 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. Looking forward to the forecast period, growth can be attributed to the escalating demand for wound care products, augmented healthcare spending in emerging markets, a focus on preventive wound care strategies, the emergence of personalized wound care solutions, and an increasing emphasis on infection control. Key trends anticipated in the forecast period involve the integration of digital health solutions into wound care management, the proliferation of wound care clinics and specialized centers, the adoption of artificial intelligence for wound assessment and treatment planning, enhanced collaboration among wound care specialists and other healthcare providers, and the development of innovative biomaterials for wound dressings.

The increasing incidence of sports injuries is poised to propel the chronic wound care market in the foreseeable future. Sports injuries, denoting physical harm or trauma incurred during sports or recreational activities, are proliferating due to various factors including intensified training regimes, inadequate warm-up routines, insufficient protective equipment, and poor technique. Chronic wound care plays a crucial role in managing the rising number of sports injuries by expediting healing, averting infections, and minimizing complications, thus facilitating a swifter return to physical pursuits. For example, as reported by the National Safety Council, a US-based non-profit organization, in March 2024, there were 3.6 million emergency department treatments for sports and recreational equipment-related injuries in 2022, marking a significant uptick from previous years. This surge indicates a 20% increase in 2021 and a further 32% increase in 2022 compared to the preceding year, with injuries associated with exercise and exercise equipment also witnessing an escalation from 2021 to 2022. Consequently, the mounting occurrences of sports injuries are propelling the chronic wound care market forward.

Prominent players in the chronic wound care market are intensifying their efforts towards developing advanced solutions, such as negative pressure wound therapy (NPWT) systems, to facilitate more convenient and comfortable home-based treatment options. NPWT systems are medical devices that administer controlled suction to wounds, fostering healing by eliminating excess fluid, reducing edema, and enhancing tissue perfusion. For instance, in April 2024, Smith & Nephew, a UK-based medical equipment manufacturer, introduced the RENASYS EDGE in the US, designed as a patient-centric solution for chronic wound treatment. Featuring a lightweight and compact design, this system boasts an intuitive interface for clinicians. Its user-friendly interface offers step-by-step guidance on therapeutic applications, complemented by technical support accessible via near-field communication during setup. Smith+Nephew also provides round-the-clock patient support and a clinical helpline. These technological advancements, including enhanced portability and near-field communication integration, not only enhance patient comfort but also cater to the growing demand for effective home-based care, potentially reducing healthcare expenses associated with chronic wound management in the wound care market.

In May 2023, LifeNet Health, a US-based non-profit organization, acquired Bioventus Inc.'s wound care division for $0.085 billion. This acquisition expands LifeNet Health's product portfolio with clinically proven solutions such as TheraSkin, TheraGenesis, and SonicOne, addressing healthcare challenges, enhancing patient care, and bolstering its position in the chronic wound care market. Bioventus Inc., a US-based medical device company specializing in chronic wound care treatments, has played a pivotal role in this arena.

Major companies operating in the chronic wound care market are Cardinal Health Inc., Johnson & Johnson, 3M Company, Medtronic PLC, Becton Dickinson and Company, Stryker Corporation, Teva Pharmaceuticals, Baxter International Inc., Essity AB (BSN Medical), Medline Industries Inc., Avery Dennison Corporation, Smith & Nephew PLC, Ethicon Inc., Coloplast AS, B. Braun Holding GmbH & Co. KG, Paul Hartmann AG, ConvaTec Group PLC, Mölnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Acelity L.P. Inc., Organogenesis Holdings Inc., MTF Biologics, MIMEDX Group Inc., Vericel Corporation, Anika Therapeutics Inc., Sigvaris Group, Marine Polymer Technologies Inc., Oneness Biotech Co. Ltd., Tissue Regenix Group PLC, Alleva Medical Ltd. (Devon Medical Products).

North America was the largest region in the chronic wound care market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic wound care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chronic wound care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Chronic wound care involves specialized medical interventions and management strategies for wounds that do not follow the typical healing trajectory within the expected timeframe, often persisting over an extended period. Its primary goal is to facilitate healing and mitigate potential complications.

Various types of chronic wound care products are available, including advanced wound dressings, surgical wound care supplies, sutures, staples, tissue adhesive and sealants, anti-infective dressings, traditional wound care items, and wound therapy devices. Advanced wound dressings encompass innovative materials directly applied to wounds to enhance healing and prevent infections, such as hydrocolloids, hydrogels, foams, and films. These products find application in treating diverse conditions such as diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others, catering to a range of end-users such as hospitals, clinics, homecare settings, among others.

The chronic wound care market research report is one of a series of new reports that provides chronic wound care market statistics, including chronic wound care industry global market size, regional shares, competitors with a chronic wound care market share, detailed chronic wound care market segments, market trends and opportunities, and any further data you may need to thrive in the chronic wound care industry. This chronic wound care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic wound care market consists of revenues earned by entities by providing services, such as wound assessment, wound debridement, infection control, wound dressing changes, negative pressure wound therapy, and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic wound care market also includes sales of debridement products, moisture control products, and antimicrobial agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.